SCHEMBL14190848

SCHEMBL14190848

Cc1ccc(Nc2nccc(Oc3c(C)cc(C)cc3C)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.52
SCN5A Q14524 1/20 0.52
SCN9A Q15858 1/20 0.52
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
RAPGEF4 Q8WZA2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
RAB9A P51151 2/20 0.42
SYK P43405 5/20 0.42
PLK4 O00444 1/20 0.41
KDR P35968 4/20 0.41
PTK2 Q05397 2/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
IGF1R P08069 1/20 0.41
MET P08581 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21514083 0.87 CYP2C9 (0.49) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL1182300 0.87 KCNH2 (0.52) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL1182645 0.81 CYP2C19 (0.57) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL21872246 0.80 CYP2C9 (0.48) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL4334006 0.78 KCNH2 (0.50) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL21872457 0.78 CYP2C9 (0.48) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL10147036 0.78 KCNH2 (0.56) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL12835455 0.77 AURKA (0.46) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL21872242 0.77 PLK4 (0.42) KCNH2SCN5ASCN9ACYP2C9CYP2C19
SCHEMBL28426672 0.77 CYP2C19 (0.51) KCNH2SCN5ASCN9ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008071587-A2 2-(PIPERIDIN-4-YL)-4-PHENOXY- OR PHENYLAMINO-PYRIMIDINE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 WO disclosed